Corporate News     22-Apr-21
Caplin receives USFDA approval for Neostigmine Methylsulfate Injection
Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Neostigmine Methylsulfate Injection USP, 5 mg/10 mL (0.5 mg/mL) and 10 mg/10 mL (1 mg/mL), Multiple-Dose vial presentations, a generic therapeutic equivalent version of (RLD), BLOXIVERZ Injection, of Exela Pharma Sciences, LLC, USA.

Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery. According to IQVIATM (IMS Health), Neostigmine Methylsulfate Injection had US sales data of approximately $20 million for the 12-month period ending Dec 2020.

Previous News
  Caplin Point Laboratories schedules AGM
 ( Corporate News - 06-Sep-22   15:28 )
  Caplin Point Laboratories to table results
 ( Corporate News - 29-Jul-22   15:40 )
  Caplin Point Laboratories standalone net profit rises 44.55% in the March 2017 quarter
 ( Results - Announcements 11-May-17   13:55 )
  Caplin Steriles receives EIR from USFDA for its unit near Chennai
 ( Corporate News - 04-Sep-23   13:56 )
  Caplin Point Laboratories fixes record date for interim dividend
 ( Market Beat - Reports 04-Mar-20   12:51 )
  Sanofi India Ltd leads losers in 'A' group
 ( Hot Pursuit - 13-Jun-24   15:00 )
  Caplin Point scales record high after stellar Q4 outcome
 ( Hot Pursuit - 11-May-17   09:51 )
  Caplin Point Laboratories consolidated net profit rises 20.23% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   14:30 )
  Caplin Point arm gets EIR from USFDA for Chennai facility
 ( Hot Pursuit - 04-Sep-23   12:11 )
  Caplin Point Laboratories consolidated net profit rises 34.20% in the June 2019 quarter
 ( Results - Announcements 13-Aug-19   16:02 )
  Caplin Point Laboratories fixes record date for interim dividend
 ( Market Beat - Reports 25-Jan-16   18:08 )
Other Stories
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
  Milkfood schedules AGM
  06-Jul-24   10:28
  Transcorp International to table results
  06-Jul-24   10:28
Back Top